Cue Biopharma, Inc. (CUE) Institutional Ownership

Ownership Summary

Recent 13F filings as of December 2025 show that 46 institutional investors hold a position in Cue Biopharma, Inc. (NASDAQ:CUE).

• Cue Biopharma saw its institutional ownership percentage rose to 20.5% in December 2025 from 17.0% in September 2025.
• The company experienced a 21.97% quarterly change in institutional shares held, alongside a decrease of 16.36% in total owners annually.
• Of these 46 institutional investors, 15 increased their holdings in Cue Biopharma, while 11 of them reduced positions, and 20 investors maintained their exposure.
• The total number of shares held by institutions in Cue Biopharma increased to 21.77Mn as of December 2025, a net change of up by 3.92Mn shares quarter on quarter, and up 10.01Mn shares year over year.
• Bleichroeder LP's holding of 6.82Mn shares as of December 31, 2025 makes it the primary institutional investor in Cue Biopharma, owning 6.41% of the stock.
• Among the most significant buyers of Cue Biopharma during December 2025 were Lion Point Capital, LP (2.20Mn), GC Wealth Management RIA, LLC (1.20Mn), Texas Capital Bank Wealth Management Services Inc (407.57K), ANGELES WEALTH MANAGEMENT, LLC (190.00K), BOOTHBAY FUND MANAGEMENT, LLC (93.33K).
• Leading sellers of Cue Biopharma stock in December 2025 included UBS Group AG (152.31K), BANK OF AMERICA CORP /DE/ (116.95K), VANGUARD GROUP INC (25.29K), WELLS FARGO & COMPANY/MN (17.01K), Sigma Planning Corp (12.25K).
• The top 10 institutional holders of Cue Biopharma for the quarter ending December 2025 included Bleichroeder LP (6.82Mn), GC Wealth Management RIA, LLC (4.63Mn), VANGUARD GROUP INC (3.01Mn), Lion Point Capital, LP (2.20Mn), GEODE CAPITAL MANAGEMENT, LLC (803.29K), BOOTHBAY FUND MANAGEMENT, LLC (704.30K), Robertson Stephens Wealth Management, LLC (478.50K), BlackRock, Inc. (449.16K), Texas Capital Bank Wealth Management Services Inc (440.67K), ANGELES WEALTH MANAGEMENT, LLC (310.00K).